Brandenburg H, Jahoda M G, Pijpers L, Wladimiroff J W
Department of Clinical Genetics, Academic Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
Am J Med Genet. 1989 Feb;32(2):225-6. doi: 10.1002/ajmg.1320320216.
In 944 Rh-negative patients who received rhesus immunoglobulin (anti-D) following genetic amniocentesis, not a single case of Rh sensitization occurred. Routine administration of a small dose (100 micrograms) of anti-D is effective in preventing Rh sensitization after midtrimester amniocentesis.